These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25309148)

  • 21. Vancomycin Dosing in Obese Patients: Special Considerations and Novel Dosing Strategies.
    Durand C; Bylo M; Howard B; Belliveau P
    Ann Pharmacother; 2018 Jun; 52(6):580-590. PubMed ID: 29262697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vancomycin dosing in obese pediatric patients.
    Moffett BS; Kim S; Edwards MS
    Clin Pediatr (Phila); 2011 May; 50(5):442-6. PubMed ID: 21282257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing Nephrotoxicity Associated With Different Vancomycin Dosing Modalities in Obese Patients at a Community Hospital.
    Wolfe A; Bowling J; Short MR; Mateyoke G; Berger SC
    Hosp Pharm; 2022 Aug; 57(4):532-539. PubMed ID: 35898248
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of a vancomycin dosing nomogram in obese patients weighing at least 100 kilograms.
    Bowers RD; Cooper AA; Wente CL; Wilson DT; Johnson SW; Drew RH
    Pharm Pract (Granada); 2018; 16(3):1204. PubMed ID: 30416622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vancomycin dosing in morbidly obese patients.
    Bauer LA; Black DJ; Lill JS
    Eur J Clin Pharmacol; 1998 Oct; 54(8):621-5. PubMed ID: 9860149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of dosing strategies and trough concentrations of vancomycin in patients undergoing continuous venovenous hemofiltration.
    Wahby KA; Cunmuljaj L; Mouabbi K; Almadrahi Z; Wilpula L
    Pharmacotherapy; 2021 Jul; 41(7):554-561. PubMed ID: 33963536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Achieving therapeutic vancomycin levels in pediatric patients.
    Hoang J; Dersch-Mills D; Bresee L; Kraft T; Vanderkooi OG
    Can J Hosp Pharm; 2014 Nov; 67(6):416-22. PubMed ID: 25548398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations.
    Frymoyer A; Guglielmo BJ; Wilson SD; Scarpace SB; Benet LZ; Hersh AL
    Pharmacotherapy; 2011 Sep; 31(9):871-6. PubMed ID: 21923588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Individualized dosing of vancomycin in geriatric patients.
    Suchánková H; Lečbychová K; Strojil J; Fürst T
    Epidemiol Mikrobiol Imunol; 2020; 69(4):172-180. PubMed ID: 33445941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of age and weight on vancomycin serum trough concentrations in pediatric patients.
    Madigan T; Sieve RM; Graner KK; Banerjee R
    Pharmacotherapy; 2013 Dec; 33(12):1264-72. PubMed ID: 23864541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of Vancomycin Levels Using Cystatin C in Overweight and Obese Patients: a Retrospective Cohort Study of Hospitalized Patients.
    Teaford HR; Stevens RW; Rule AD; Mara KC; Kashani KB; Lieske JC; O'Horo J; Barreto EF
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33106257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vancomycin Pharmacokinetics in Obese Patients with Sepsis or Septic Shock.
    Masich AM; Kalaria SN; Gonzales JP; Heil EL; Tata AL; Claeys KC; Patel D; Gopalakrishnan M
    Pharmacotherapy; 2020 Mar; 40(3):211-220. PubMed ID: 31957057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a vancomycin dosing nomogram in achieving high target trough concentrations in Taiwanese patients.
    Leu WJ; Liu YC; Wang HW; Chien HY; Liu HP; Lin YM
    Int J Infect Dis; 2012 Nov; 16(11):e804-10. PubMed ID: 22917921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An evaluation of initial vancomycin dosing in infants, children, and adolescents.
    Broome L; So TY
    Int J Pediatr; 2011; 2011():470364. PubMed ID: 22046192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vancomycin dosing and target attainment in children.
    Hwang D; Chiu NC; Chang L; Peng CC; Huang DT; Huang FY; Chi H
    J Microbiol Immunol Infect; 2017 Aug; 50(4):494-499. PubMed ID: 26462708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatric Obesity: Pharmacokinetics and Implications for Drug Dosing.
    Kendrick JG; Carr RR; Ensom MH
    Clin Ther; 2015 Sep; 37(9):1897-923. PubMed ID: 26361823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of initial serum vancomycin trough concentrations and their association with initial empirical weight-based vancomycin dosing and development of nephrotoxicity in children: a multicenter retrospective study.
    Matson KL; Shaffer CL; Beck GL; Simonsen KA
    Pharmacotherapy; 2015 Mar; 35(3):337-43. PubMed ID: 25756622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pediatric Assessment of Vancomycin Empiric Dosing (PAVED): a Retrospective Review.
    Rainkie D; Ensom MH; Carr R
    Paediatr Drugs; 2015 Jun; 17(3):245-53. PubMed ID: 25813682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Effectiveness of a Vancomycin Dosing Guideline in the Neonatal Intensive Care Unit for Achieving Goal Therapeutic Trough Concentrations.
    Reilly AM; Ding MX; Rower JE; Kiser TH
    J Clin Pharmacol; 2019 Jul; 59(7):997-1005. PubMed ID: 30776089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center.
    Meng L; Wong T; Huang S; Mui E; Nguyen V; Espinosa G; Desai J; Holubar M; Deresinski S
    Pharmacotherapy; 2019 Apr; 39(4):433-442. PubMed ID: 30739349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.